<DOC>
	<DOCNO>NCT00653380</DOCNO>
	<brief_summary>To compare rate extent absorption doxycycline monohydrate capsule equivalent 100 mg doxycycline ( Par ) versus Monodox ( Oclassen Pharmaceuticals ) .</brief_summary>
	<brief_title>Bioavailability Study Doxycycline Monohydrate Capsules Monodox Under Fasting Conditions</brief_title>
	<detailed_description>To compare rate extent absorption doxycycline monohydrate capsule equivalent 100 mg doxycycline Par Pharmaceutical , Inc. , USA ( test ) versus Monodox Oclassen Pharmaceuticals , Inc. , USA reference administer 1 x 100 mg capsule fast condition .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Subjects male , nonsmoker Between 18 55 year age Subjects weight within 15 % ideal body weight , base Table `` Desirable Weight Adults '' , Metropolitan Life Insurance Company , 1983 Subjects read , sign date Informed Consent Form prior study procedure Subjects must complete screening procedure within 28 day prior administration study medication Clinically significant abnormality find medical screen Any clinically significant history ongoing problem problem know interfere absorption , distribution , metabolism excretion drug drug Clinically significant illness within 4 week administration study medication Abnormal laboratory test judge clinically significant ECG vital sign abnormality ( clinically significant ) History allergic reaction heparin Any food allergy , intolerance , restriction , special diet opinion medical subinvestigator , contraindicate subject 's participation study History severe allergy hay fever Active asthma bronchospasm Positive urine drug screen screen Positive test hepatitis B , hepatitis C HIV screen Use investigational drug participation investigational study , within 30 day prior administration study medication Recent donation plasma ( 500 mL ) within 7 day recent donation significant loss whole blood ( 450 mL ) within 56 day prior administration study medication History significant alcohol abuse within six month screen visit indication regular use two unit alcohol per day Recent history drug abuse use illegal drug : soft drug ( marijuana , pot ) use within 3 month screen visit hard drug ( cocaine , PCP , crack ) use within 1 year screen visit Subjects take prescription medication 14 day precede administration study medication overthecounter product 7 day precede administration study medication , except topical product without systemic absorption Subjects take drug know induce inhibit hepatic drug metabolism within 30 day prior administration study medication Subjects undergone clinically significant surgery within 4 week prior administration study medication Any reason , opinion medical subinvestigator , would prevent subject participate study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>doxycycline monohydrate</keyword>
	<keyword>fast</keyword>
</DOC>